NewsLifting Of Natural CBD Cosmetics’ Ban In Europe

Lifting Of Natural CBD Cosmetics’ Ban In Europe

-

THE lifting of a ban on the use of CBD in creams and cosmetics will be a major boost for smaller European businesses.

In early 2019 the European Commission (EC) introduced new non-legally binding provisions which outlawed the use of natural CBD in cosmetics in favour of synthetic CBD. 

However, the European Industrial Hemp Association (EIHA)  has successfully overturned the decision following an intensive lobbying campaign, led by its Managing Director Lorenza Romanese.

Ms Romanese said: “The initial change only suited a few cosmetic companies as synthetics are extremely expensive. The process  involved also produces a lot of chemical waste, which needs to be recycled at a later stage. 

“But, the European Commission have changed the catalog and we can now use leaves in cream and other cosmetics.  This is a massive boost for the wider European industry and the smaller hemp and CBD business we represent.” 

The EC’s decision to outlaw natural CBD is rooted in the confusing legal position of cannabis and hemp, not just in Europe, but across the whole world. 

European cosmetic regulators chose to create a new classification for CBD, based on a strict interpretation of the 1961 Single Convention on Narcotic Drugs (SCND).

The Cosing database – the Inventory of Cosmetic Ingredients – was thus updated to outlaw CBD ‘derived from extract or tincture or resin of cannabis’ whilst it surprisingly approved ‘synthetically-produced CBD’. 

However, the EIHA pointed out that industrial hemp is clearly excluded from the SCND’s banned ingredients list, which, also does not include ‘cannabis seeds or leaves without fruiting tops’.

And, it highlighted how CBD, derived from these parts of the cannabis plant, is not outlawed in Europe. Ms Romanese said: “The decision last April was based on the view CBD was a narcotic, but we proved to them that industrial hemp is excluded from the SCND as it is not a drug, and does not have psychotropic effects.”

This comes as the global demand for CBD Skincare and beauty products is growing rapidly.

A new report from Prohibition Partners ‘Disrupting Beauty’ says CBD products could account for 10% of global skin-care sales, and values the global CBD skincare market at nearly $1bn, within five years.

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Medical Cannabis Could Be Available In Spain By The End Of The Year

SPAIN could now see the regulation and distribution of medical cannabis rolled out before the end of the year...

New UK Company Heralds Its ‘Unique’ Medical Cannabis Delivery Mechanism

CANNABIS extraction and formulations specialist 113 Botanicals is in the process of securing Good manufacturing Practice (GMP) compliance for...

German Cannabis Bill By Year End With Adult-Use Launch Likely In Early 2024

GERMANY’s draft cannabis law should be ready by the end of the year with the launch of its adult-use...

Must read

You might also likeRELATED
Recommended to you